1. Stop TB Partnership. Working Group for New TB Drugs. 2022 Global New TB drug pipeline, https://www.newtbdrugs.org/pipeline/discovery; n.d. [accessed 18 January 2023].
2. Anti-tuberculosis treatment strategies and drug development: challenges and priorities;Dartois;Nat Rev Microbiol,2022
3. Global Advocacy for HIV Prevention (AVAC). Good participatory practice: guidelines for TB drug trials: Critical path to TB drug regimens, https://www.avac.org/resource/good-participatory-practice-guidelines-tb-drug-trials; 2012 [accessed 12 January 2023].
4. World Health Organization. Community engagement to support universal access to diagnosis, care and treatment of drug-resistant TB, https://www.ncbi.nlm.nih.gov/books/NBK247407/; 2014 [accessed 18 January 2023].
5. Critical Path to TB Drug Regimens' Stakeholder and Community Engagement Workgroup. Engaging communities in tuberculosis research;Boulanger;Lancet Infect Dis,2013